Orchid Enters Into Pact With U.S.-Based STADA Pharmaceuticals

The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid), has entered into an exclusive agreement with STADA Pharmaceuticals Inc, the U.S. subsidiary of STADA Arzneimittel AG, for the development and supply of six prescription generic drug products to STADA for the US market. Through this agreement, the company will develop and exclusively manufacture these non-cephalosporin formulations for exclusive distribution and marketing by STADA in the US market.

Express Pharma Pulse (http://www.expresspharmapulse.com/20050324/corporate02.shtml)